| Date Filed | Type | Description |
| 06/09/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/07/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 8,650 shares
@ $0
Granted 11,893 options to buy
@ $23.48, valued at
$279.2k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 1,364 shares
@ $22.79, valued at
$31.1k
|
|
| 03/11/2022 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 19,493 shares
@ $34.73, valued at
$677k
Sold 12,069 shares
@ $35.48, valued at
$428.2k
Exercised 31,562 options to buy
@ $1.63, valued at
$51.4k
|
|
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2019 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 05/07/2019 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 16,000 options to buy
@ $17.15, valued at
$274.4k
|
|
| 12/26/2018 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 50,000 shares
@ $0.4129, valued at
$20.6k
Bought 195,000 shares
@ $0.4236, valued at
$82.6k
|
|
| 12/07/2018 |
3
| MENDLEIN JOHN (See Remarks) has filed a Form 3 on Moderna, Inc. |
| 05/17/2018 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $1.35, valued at
$27k
|
|
| 05/04/2018 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 16,000 options to buy
@ $9.78, valued at
$156.5k
|
|
| 01/02/2018 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 32,000 options to buy
@ $3.8, valued at
$121.6k
|
|
| 09/05/2017 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 37,736 shares
@ $2.65, valued at
$100k
Bought 14,151 options to buy
@ $4.64, valued at
$65.7k
|
|
| 06/19/2017 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $15.63, valued at
$180.3k
|
|
| 05/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2017 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC |
| 04/20/2017 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC |
| 02/09/2017 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC |
| 12/21/2016 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC |
| 05/13/2016 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $1.69, valued at
$42.3k
|
|
| 04/07/2016 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 2,500 shares
@ $3.52, valued at
$8.8k
|
|
| 04/06/2016 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 2,500 shares
@ $3.55, valued at
$8.9k
|
|
| 02/04/2016 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 96,153 options to buy
@ $16, valued at
$1.5M
|
|
| 01/29/2016 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 135,000 options to buy
@ $6.14, valued at
$828.9k
|
|
| 01/06/2016 |
4
| MENDLEIN JOHN (CEO and Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 148,732 options to buy
@ $9.13, valued at
$1.4M
|
|
| 10/05/2015 |
4
| MENDLEIN JOHN (See Remarks) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 71,000 options to buy
@ $10.24, valued at
$727k
Granted 65,070 options to buy
@ $10.24, valued at
$666.3k
|
|
| 05/15/2015 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $7.08, valued at
$70.8k
|
|
| 05/14/2015 |
4
| MENDLEIN JOHN (CEO and Executive Chairman) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Converted 24,055 shares
@ $0
Converted 170,218 options to buy
@ $0
Converted 21,122 options to buy
@ $0 |
|
|